'Pepc rituximab' diaporamas de présentation

Pepc rituximab - PowerPoint PPT Presentation


Which of the following are treatment options for relapsed MCL? Select all that apply.

Which of the following are treatment options for relapsed MCL? Select all that apply.

Which of the following are treatment options for relapsed MCL? Select all that apply. [X]. [ ]. Bortezomib ± rituximab. NORDIC. [ ]. [X]. CVP. PEPC ± rituximab. [X]. [ ]. FMR. R-CHOP. [X]. [ ]. Lenalidomide ± rituximab. RICE.

By zizi
(112 views)


View Pepc rituximab PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Pepc rituximab PowerPoint presentations. You can view or download Pepc rituximab presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

Recherches associées pour Pepc rituximab
PEPC

PEPC

iRT. irT. N. +3. +6. N. +3. +6. 4CL-L. 4CL-2. CHS4. CHS5. CHS7/CHS8. LAR1. DFR2. ANS2/ANS3. ANR1. UGT78K1. UGT78K2. OMT-like. OMT5. GST26. GST21. MYB50. MYB159. C2H2 ZF. *WD40. SCOF-1. AP2. EF-hand. *ProtK. *LRR. G4DT. PAO1-L. *Am Oxy. *PCT. PUB22. *9O12a.

By benny (126 views)

RITUXIMAB

RITUXIMAB

RITUXIMAB. RITUXIMAB et Pathologies Auto immunes Christelle Gibert- Valence novembre 2006. Une biothérapie d’avenir. - Rôle clé des Lymphocytes B dans les maladies auto-immunes : rôle de CPA : - présentateurs d’autoAg et - capable d’activer des LT autoréactifs.

By bradley (196 views)

How to Document-Code PEPC

How to Document-Code PEPC

How to Document-Code PEPC. Indian Health Service Health Education Program 2010. There are 2 PEPC Manuals. Both are located at www.ihs.gov Volume I gives information on ‘how to document’ Volume II is the actual Protocols or guidelines of what to teach. Standard Education across IHS.

By betha (102 views)

How to Document-Code PEPC

How to Document-Code PEPC

How to Document-Code PEPC. Indian Health Service Health Education Program 2010. There are 2 PEPC Manuals. Both are located at www.ihs.gov Volume I gives information on ‘how to document’ Volume II is the actual Protocols or guidelines of what to teach. Standard Education across IHS.

By mendozas (0 views)

RITUXIMAB ET LUPUS PEDIATRIQUE

RITUXIMAB ET LUPUS PEDIATRIQUE

RITUXIMAB ET LUPUS PEDIATRIQUE. Rituximab et LED pédiatrique. 3 séries pédiatriques 1 prospective : Podolskaya,ADC 2007 2 rétrospectives Bader-Meunier, J Pediatr 2007 Nwobi, Pediatr Nephrol 2008. 48 patients!. LED réfractaires Atteinte rénale Atteinte articulaire Atteinte neurologique

By helen (225 views)

Rituximab in autoimmune diseases

Rituximab in autoimmune diseases

Rituximab in autoimmune diseases. 自身免疫性疾病概述. 自身免疫性疾病( autoimmune diseases )是指机体对自身抗原发生免疫反应而导致自身组织损害所引起的疾病。 常见的自身免疫病有:系统性红斑狼疮、类风湿性关节炎、硬皮病、原发性血小板紫癜、自身免疫性溶血性贫血等等。. 自身免疫性疾病概述. 特点:①患者血液中可测行高效价自身抗体和(或)自身组织成分起反应的致敏淋巴细胞。②自身抗体和(或)自身致敏淋巴细胞作用于靶抗原所在组织、细胞,造成相应组织器官的病理性损伤和功能障碍。.

By halla-moss (266 views)

RITUXIMAB - VASCULARITES à ANCA

RITUXIMAB - VASCULARITES à ANCA

RITUXIMAB - VASCULARITES à ANCA. GIB 04/02/2010 Loïc RAFFRAY. PREAMBULE. Vascularites à ANCA : Gravité Échec ttt : 20-30% en 1ere ligne Rechutes : 50% GW, 30% PAM, 25% CS

By louis (158 views)

Cladribine + Rituximab in HCL : UPDATE

Cladribine + Rituximab in HCL : UPDATE

Cladribine + Rituximab in HCL : UPDATE. Farhad Ravandi, MD Professor of Medicine University of Texas – M. D. Anderson Cancer Center. HCL - Questions. Can we design a regimen with higher efficacy than single agent nucleoside analogs? (with no increased toxicity)

By sonja (157 views)